Bridge to Life, Ltd.

Jun 24, 2025

Bridge to Life Announces New FDA-Approved Indication for EasiSlush® Sodium Chloride Solution for Slush Preparation

May 15, 2025

Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025

Dec 18, 2024

Bridge to Life Acquires VitaSmart(TM) Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.

Nov 14, 2024

Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart(TM) System

Oct 25, 2024

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of Livers Awaiting Transplantation

Oct 21, 2024

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

Jun 04, 2024

Latest Results from End-Ischemic HOPE U.S. Randomized Clinical Trial for Liver Transplantation Show Safety, Reduced Early Allograft Dysfunction, and Shorter Hospital Stays with HOPE

Apr 02, 2024

Bridge to Life Announces Abstract Presentations at The European Society for Transplantation's ELITA Summit 2024 in Madrid, Spain, April 18-20, 2024

Feb 05, 2024

Bridge to Life Reintroduces EasiSlush® to the US Market, Meeting High Demand for Easy-to-Use Sterile Slush for Organ Transplantation